Income Statement Dr. Reddy's Laboratories Limited

Stocks

DRREDDY

INE089A01031

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:29:28 13/07/2026 BST			5-day change	1st Jan Change
1,234.60 ^INR	-0.88%		-10.18%	-2.87%

03:57pm	Asian Equities Traded in the US as American Depositary Receipts Advance in Monday Trading	MT
07-10	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT

f1ca93583f0c.a6ZVWscUHGGf3KYgrdcyXU4Zauyy2Uvx7T6Z3TLM_o0.H81lIqh5a1TLqfRQz5ttOjtjBr_LryCLuAr1p2uVoc8k5xwotV5wCcWm8w

Published financial data: DR. REDDY'S LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	214B	246B	279B	326B	336B
Total Revenues	214B	246B	279B	326B	336B
Cost of Goods Sold, Total	101B	107B	116B	135B	159B
Gross Profit	114B	139B	164B	190B	177B
Selling General & Admin Expenses, Total	62.08B	68.03B	77.2B	92.85B	107B
R&D Expenses	17.48B	19.38B	22.87B	27.38B	24.06B
Other Operating Expenses	-1.64B	-1.48B	-1.78B	-2.84B	-2.8B
Other Operating Expenses, Total	77.92B	85.93B	98.3B	117B	128B
Operating Income	35.92B	53.42B	65.31B	73.03B	49.25B
Interest Expense, Total	-958M	-1.43B	-1.71B	-2.83B	-3.74B
Interest And Investment Income	965M	1.18B	2.28B	2.68B	3.73B
Net Interest Expenses	7M	-248M	567M	-152M	-12M
Income (Loss) On Equity Invest.	703M	370M	147M	217M	134M
Currency Exchange Gains (Loss)	1.84B	2.22B	278M	1.32B	1.78B
Other Non Operating Income (Expenses)	-	-	46M	3.55B	2.36B
EBT, Excl. Unusual Items	38.46B	55.76B	66.35B	77.97B	53.51B
Merger & Related Restructuring Charges	-	-	-	-1.02B	-
Gain (Loss) On Sale Of Investments	277M	876M	3.1B	-	-
Gain (Loss) On Sale Of Assets	1.12B	-1.21B	900M	1.52B	2.55B
Asset Writedown	-7.56B	-699M	-3M	-1.69B	-3.52B
Legal Settlements	-	5.64B	1.52B	-	1.4B
Other Unusual Items	-	-	-	-	877M
EBT, Incl. Unusual Items	32.3B	60.37B	71.87B	76.78B	54.82B
Income Tax Expense	8.73B	15.3B	16.19B	19.54B	12.35B
Earnings From Continuing Operations	23.57B	45.07B	55.68B	57.24B	42.47B
Net Income to Company	23.57B	45.07B	55.68B	57.24B	42.47B
Minority Interest	-	-	-	-701M	384M
Net Income - (IS)	23.57B	45.07B	55.68B	56.54B	42.85B
Net Income to Common Incl Extra Items	23.57B	45.07B	55.68B	56.54B	42.85B
Net Income to Common Excl. Extra Items	23.57B	45.07B	55.68B	56.54B	42.85B
Per Share Items
Net EPS - Basic	28.42	54.29	66.93	67.88	51.48
Basic EPS - Continuing Operations	28.42	54.29	66.93	67.88	51.48
Basic Weighted Average Shares Outstanding	829M	830M	832M	833M	832M
Net EPS - Diluted	28.34	54.17	66.8	67.78	51.42
Diluted EPS - Continuing Operations	28.34	54.17	66.8	67.78	51.42
Diluted Weighted Average Shares Outstanding	832M	832M	834M	834M	833M
Normalized Basic EPS	28.98	41.98	49.84	57.66	40.64
Normalized Diluted EPS	28.9	41.89	49.75	57.58	40.59
Dividend Per Share	6	8	8	8	8
Payout Ratio	17.59	11.05	11.94	11.78	15.54
American Depositary Receipts Ratio (ADR)	0.17	0.17	0.17	0.17	0.17
Supplemental Items
EBITDA	46.88B	65.17B	79.01B	88.84B	68.15B
EBITA	39.59B	57.44B	70.57B	79.58B	57.23B
EBIT	35.92B	53.42B	65.31B	73.03B	49.25B
EBITDAR	-	-	79.04B	88.88B	68.19B
Effective Tax Rate - (Ratio)	27.03	25.34	22.52	25.45	22.53
Current Domestic Taxes	4.18B	8.77B	13.87B	17.91B	9.6B
Current Foreign Taxes	2.23B	4.09B	5.58B	4.67B	4.35B
Total Current Taxes	6.41B	12.86B	19.46B	22.58B	13.95B
Deferred Domestic Taxes	2.16B	3.89B	968M	-1.07B	945M
Deferred Foreign Taxes	154M	-1.45B	-4.24B	-1.97B	-2.54B
Total Deferred Taxes	2.32B	2.44B	-3.27B	-3.04B	-1.6B
Normalized Net Income	24.04B	34.85B	41.47B	48.03B	33.83B
Interest Capitalized	421M	426M	488M	729M	983M
Interest on Long-Term Debt	221M	214M	256M	391M	802M
Non-Cash Pension Expense	43M	51M	-4M	19M	928M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	17.48B	19.38B	22.87B	27.38B	24.06B
Net Rental Expense, Total	-	-	37M	39M	41M
Imputed Operating Lease Interest Expense	-	-	38.87M	33.24M	24.95M
Imputed Operating Lease Depreciation	-	-	-1.87M	5.76M	16.05M
Stock-Based Comp., Other (Total)	740M	644M	821M	796M	623M
Total Stock-Based Compensation	740M	644M	821M	796M	623M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	14.85B	5.78B	7.11B	14.65B	15.37B
Short Term Investments	29.51B	56.02B	74.36B	43.25B	72.45B
Total Cash And Short Term Investments	44.36B	61.8B	81.47B	57.91B	87.81B
Accounts Receivable, Total	66.76B	72.48B	80.3B	90.42B	101B
Other Receivables	5.05B	3.28B	2.91B	2.97B	444M
Total Receivables	71.82B	75.77B	83.21B	93.39B	102B
Inventory	50.88B	48.67B	63.55B	71.08B	76.53B
Prepaid Expenses	1.14B	1.45B	1.95B	1.88B	2.08B
Other Current Assets, Total	13.65B	19.25B	17.87B	25.85B	33.89B
Total Current Assets	182B	207B	248B	250B	302B
Gross Property Plant And Equipment	142B	152B	170B	190B	220B
Accumulated Depreciation	-79.73B	-85.81B	-93.26B	-92.62B	-104B
Net Property Plant And Equipment	62.17B	66.46B	76.89B	97.76B	116B
Long-term Investments	7.99B	5.36B	5.26B	15.2B	16.37B
Goodwill	4.42B	4.24B	4.25B	11.81B	12.89B
Other Intangibles, Total	27.25B	30.85B	36.95B	96.8B	105B
Accounts Receivable Long-Term	54M	-	-	-	-
Deferred Tax Assets Long-Term	8.2B	7.2B	10.77B	18.51B	22.44B
Other Long-Term Assets, Total	894M	800M	5.35B	2.79B	4.68B
Total Assets	293B	322B	388B	493B	579B
Liabilities
Accounts Payable, Total	15.97B	17.86B	21.55B	20.05B	22.36B
Accrued Expenses, Total	36.08B	38.72B	40.49B	43.86B	47.46B
Short-term Borrowings	27.08B	7.39B	12.72B	38.04B	59.14B
Current Portion of Long-Term Debt	-	3.8B	-	-	3.8B
Current Portion of Leases	1.02B	1B	1.31B	857M	2.2B
Current Income Taxes Payable	1.62B	2.14B	2.34B	3.03B	4.31B
Unearned Revenue Current, Total	2.58B	1.98B	1.44B	1.98B	1.58B
Other Current Liabilities	9.67B	12.95B	16.19B	22.56B	26.71B
Total Current Liabilities	94.02B	85.84B	96.04B	130B	168B
Long-Term Debt	3.8B	-	3.8B	3.8B	-
Long-Term Leases	1.95B	1.28B	2.19B	4.06B	12.2B
Unearned Revenue Non Current	1.6B	1.56B	1.19B	1.16B	2.44B
Deferred Tax Liability Non Current	60M	833M	909M	14.11B	15.57B
Other Non Current Liabilities	882M	1.35B	2.84B	2.3B	1.12B
Total Liabilities	102B	90.86B	107B	156B	199B
Common Stock, Total	832M	833M	834M	834M	835M
Additional Paid In Capital	9.28B	9.69B	10.76B	11.13B	11.36B
Retained Earnings	176B	216B	266B	316B	352B
Treasury Stock	-1.6B	-1.27B	-991M	-2.26B	-1.82B
Comprehensive Income and Other	5.55B	5.26B	4.03B	7.89B	14.7B
Total Common Equity	191B	231B	281B	333B	377B
Minority Interest	-	-	-	3.78B	3.39B
Total Equity	191B	231B	281B	337B	380B
Total Liabilities And Equity	293B	322B	388B	493B	579B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	830M	831M	833M	832M	833M
ECS Total Common Shares Outstanding	830M	831M	833M	832M	833M
Book Value / Share	229.61	278.04	336.94	400.71	452.82
Tangible Book Value	159B	196B	239B	225B	259B
Tangible Book Value Per Share	191.45	235.8	287.45	270.16	311.17
Total Debt	33.84B	13.47B	20.02B	46.77B	77.34B
Net Debt	-10.52B	-48.32B	-61.45B	-11.14B	-10.47B
Debt Equivalent of Unfunded Proj. Benefit Obligation	600M	26M	357M	524M	-16M
Debt Equivalent Oper. Leases	-	-	296M	312M	328M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	3.78B	3.39B
Equity Method Investments, Total	4.32B	4.7B	4.2B	4.81B	5.67B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	17.51B	16B	24.08B	26.16B	27.38B
Inventories - Work In Process, Total	12.89B	11.7B	14.22B	16.52B	16.05B
Inventories - Finished Goods, Total	20.49B	20.97B	25.25B	28.4B	33.1B
Land - (BS)	4.15B	4.23B	4.22B	4.16B	4.24B
Buildings, Total	24.66B	26.52B	27.99B	28.34B	31.75B
Machinery, Total	95.1B	107B	117B	125B	153B
Full Time Employees	24.8K	25.86K	27.05K	27.81K	27.53K
Accumulated Allowance for Doubtful Accounts (Supple)	1.19B	1.26B	1.45B	1.48B	1.85B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	23.57B	45.07B	55.68B	56.54B	42.85B
Depreciation & Amortization - CF	8.15B	8.62B	9.58B	10.5B	12.62B
Amortization of Goodwill and Intangible Assets - (CF)	3.67B	4.02B	5.26B	6.55B	7.98B
Depreciation & Amortization, Total	11.82B	12.64B	14.84B	17.06B	20.6B
(Gain) Loss From Sale Of Asset	-1.12B	208M	-900M	-1.52B	-2.55B
(Gain) Loss on Sale of Investments - (CF)	-277M	-876M	-3.15B	-3.55B	-2.36B
Asset Writedown & Restructuring Costs	7.56B	699M	3M	1.69B	3.52B
(Income) Loss On Equity Investments - (CF)	-703M	-370M	-147M	-217M	-134M
Stock-Based Compensation (CF)	592M	397M	407M	424M	326M
Provision and Write-off of Bad Debts	55M	205M	275M	161M	690M
Other Operating Activities, Total	520M	8.76B	-1.4B	5.83B	5.44B
Change In Accounts Receivable	-17.01B	-5.75B	-8.05B	-10.28B	-6.72B
Change In Inventories	-5.33B	-2.65B	-18.44B	-12.75B	-8.6B
Change In Accounts Payable	4.41B	23M	3.46B	340M	2.79B
Change in Other Net Operating Assets	4.01B	528M	2.86B	-7.29B	897M
Cash from Operations	28.11B	58.88B	45.43B	46.43B	56.76B
Capital Expenditure	-14.66B	-11.32B	-16.4B	-27.5B	-23.33B
Sale of Property, Plant, and Equipment	370M	82M	1.06B	512M	309M
Cash Acquisitions	-326M	-	-	-53.1B	-3.15B
Sale (Purchase) of Intangible assets	-1.44B	-7.54B	-11.01B	-6.16B	-13.7B
Investment in Marketable and Equity Securities, Total	-11.2B	-23.37B	-15.72B	24.8B	-27.17B
Other Investing Activities, Total	873M	777M	1.78B	3.37B	1.52B
Cash from Investing	-26.39B	-41.37B	-40.28B	-58.08B	-65.51B
Short Term Debt Issued, Total	3.52B	-	5.49B	24.49B	20.26B
Long-Term Debt Issued, Total	-	-	3.8B	-	-
Total Debt Issued	3.52B	-	9.29B	24.49B	20.26B
Short Term Debt Repaid, Total	-	-19.38B	-	-	-
Long-Term Debt Repaid, Total	-785M	-1.02B	-4.95B	-1.29B	-1.26B
Total Debt Repaid	-785M	-20.4B	-4.95B	-1.29B	-1.26B
Issuance of Common Stock	334M	368M	805M	193M	397M
Repurchase of Common Stock	-	-	-	-1.39B	-
Common Dividends Paid	-4.15B	-4.98B	-6.65B	-6.66B	-6.66B
Common & Preferred Stock Dividends Paid	-4.15B	-4.98B	-6.65B	-6.66B	-6.66B
Other Financing Activities, Total	-1.34B	-1.85B	-2.27B	3.57B	-4.44B
Cash from Financing	-2.42B	-26.86B	-3.76B	18.91B	8.29B
Foreign Exchange Rate Adjustments	733M	286M	-59M	224M	1.24B
Net Change in Cash	32M	-9.07B	1.33B	7.49B	775M
Supplemental Items
Cash Interest Paid	1.34B	1.85B	2.27B	3.48B	4.44B
Cash Income Tax Paid (Refund)	7.44B	10.71B	20.05B	19.99B	13.53B
Levered Free Cash Flow	1.03B	26.99B	12.23B	11.92B	1.63B
Unlevered Free Cash Flow	1.63B	27.88B	13.3B	13.69B	3.96B
Change In Net Working Capital	17.28B	-83M	15.76B	16.14B	11.02B
Net Debt Issued / Repaid	2.74B	-20.4B	4.35B	23.2B	18.99B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	8.04	10.86	11.51	10.37	5.74
Return on Total Capital	10.5	14.24	14.98	13.34	7.31
Return On Equity %	12.96	21.38	21.77	18.53	11.84
Return on Common Equity	12.96	21.38	21.77	18.42	12.06
Margin Analysis
Gross Profit Margin %	53.1	56.67	58.61	58.5	52.77
SG&A Margin	28.96	27.67	27.65	28.52	31.78
EBITDA Margin %	21.87	26.51	28.3	27.29	20.29
EBITA Margin %	18.47	23.36	25.28	24.45	17.04
EBIT Margin %	16.75	21.72	23.39	22.43	14.66
Income From Continuing Operations Margin %	10.99	18.33	19.95	17.58	12.64
Net Income Margin %	10.99	18.33	19.95	17.37	12.76
Net Avail. For Common Margin %	10.99	18.33	19.95	17.37	12.76
Normalized Net Income Margin	11.21	14.17	14.85	14.75	10.07
Levered Free Cash Flow Margin	0.48	10.98	4.38	3.66	0.48
Unlevered Free Cash Flow Margin	0.76	11.34	4.76	4.2	1.18
Asset Turnover
Asset Turnover	0.77	0.8	0.79	0.74	0.63
Fixed Assets Turnover	3.59	3.82	3.89	3.73	3.14
Receivables Turnover (Average Receivables)	3.68	3.53	3.65	3.81	3.51
Inventory Turnover (Average Inventory)	2.09	2.14	2.06	2.01	2.15
Short Term Liquidity
Current Ratio	1.93	2.41	2.58	1.92	1.8
Quick Ratio	1.24	1.6	1.71	1.16	1.13
Operating Cash Flow to Current Liabilities	0.3	0.69	0.47	0.36	0.34
Days Sales Outstanding (Average Receivables)	99.09	103.36	100.15	95.71	104.11
Days Outstanding Inventory (Average Inventory)	174.78	170.54	177.72	181.86	169.79
Average Days Payable Outstanding	49.35	59.18	55.28	53.22	47.17
Cash Conversion Cycle (Average Days)	224.52	214.72	222.59	224.35	226.73
Long Term Solvency
Total Debt/Equity	17.76	5.83	7.14	13.87	20.33
Total Debt / Total Capital	15.08	5.51	6.66	12.18	16.89
LT Debt/Equity	3.02	0.55	2.14	2.33	3.21
Long-Term Debt / Total Capital	2.56	0.52	1.99	2.05	2.67
Total Liabilities / Total Assets	34.94	28.23	27.6	31.61	34.33
EBIT / Interest Expense	37.49	37.41	38.17	25.82	13.17
EBITDA / Interest Expense	49.84	46.25	46.84	31.84	18.69
(EBITDA - Capex) / Interest Expense	34.53	38.33	37.26	22.12	12.45
Total Debt / EBITDA	0.71	0.2	0.25	0.52	1.11
Net Debt / EBITDA	-0.22	-0.73	-0.77	-0.12	-0.15
Total Debt / (EBITDA - Capex)	1.02	0.25	0.31	0.75	1.66
Net Debt / (EBITDA - Capex)	-0.32	-0.88	-0.96	-0.18	-0.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13	14.69	13.54	16.61	3.19
Gross Profit, 1 Yr. Growth %	10.44	22.4	17.41	16.39	-6.91
EBITDA, 1 Yr. Growth %	4.34	39.01	21.22	12.05	-22.4
EBITA, 1 Yr. Growth %	6.32	45.08	22.87	12.32	-27.16
EBIT, 1 Yr. Growth %	8.94	48.71	22.26	11.35	-31.62
Earnings From Cont. Operations, 1 Yr. Growth %	36.72	91.22	23.56	2.8	-25.82
Net Income, 1 Yr. Growth %	36.72	91.22	23.56	1.54	-24.22
Normalized Net Income, 1 Yr. Growth %	11.34	44.97	19.3	10.21	-28.62
Diluted EPS Before Extra, 1 Yr. Growth %	36.7	91.16	23.32	1.47	-24.14
Accounts Receivable, 1 Yr. Growth %	34.49	8.57	10.78	12.61	11.94
Inventory, 1 Yr. Growth %	12.05	-4.35	30.58	11.85	7.66
Net Property, Plant and Equip., 1 Yr. Growth %	8.86	6.91	15.68	27.15	18.59
Total Assets, 1 Yr. Growth %	10.3	9.91	20.4	27.22	17.52
Tangible Book Value, 1 Yr. Growth %	19.58	23.31	22.18	-6.09	15.28
Common Equity, 1 Yr. Growth %	10.09	21.24	21.45	18.83	13.1
Cash From Operations, 1 Yr. Growth %	-21.27	109.46	-22.83	2.19	22.24
Capital Expenditures, 1 Yr. Growth %	50.5	-22.76	44.86	67.68	-15.19
Levered Free Cash Flow, 1 Yr. Growth %	-94.66	2.52K	-58.79	-3.92	-85.58
Unlevered Free Cash Flow, 1 Yr. Growth %	-91.81	1.61K	-56.49	1.58	-69.63
Dividend Per Share, 1 Yr. Growth %	20	33.33	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.81	13.84	14.11	15.06	9.7
Gross Profit, 2 Yr. CAGR %	10.04	16.27	19.88	16.9	4.09
EBITDA, 2 Yr. CAGR %	5.93	19.41	28.64	15.97	-7.12
EBITA, 2 Yr. CAGR %	9.29	24.29	33.51	17.71	-9.95
EBIT, 2 Yr. CAGR %	10.7	27.4	34.84	16.93	-13.16
Earnings From Cont. Operations, 2 Yr. CAGR %	9.94	61.69	53.71	12.7	-12.67
Net Income, 2 Yr. CAGR %	9.94	61.69	53.71	12.01	-12.28
Normalized Net Income, 2 Yr. CAGR %	12.44	26.15	30.86	16.48	-11.72
Diluted EPS Before Extra, 2 Yr. CAGR %	9.86	61.65	53.54	11.86	-12.26
Accounts Receivable, 2 Yr. CAGR %	15.23	20.84	9.67	11.69	12.27
Inventory, 2 Yr. CAGR %	20.46	3.52	11.76	20.85	9.74
Net Property, Plant and Equip., 2 Yr. CAGR %	8.99	7.88	11.21	21.28	22.79
Total Assets, 2 Yr. CAGR %	12.29	10.1	15.04	23.76	22.27
Tangible Book Value, 2 Yr. CAGR %	13.49	21.43	22.74	7.12	4.05
Common Equity, 2 Yr. CAGR %	10.87	15.53	21.35	20.14	15.93
Cash From Operations, 2 Yr. CAGR %	-2.95	28.41	27.14	-11.2	11.77
Capital Expenditures, 2 Yr. CAGR %	73.93	7.81	5.78	55.85	19.25
Levered Free Cash Flow, 2 Yr. CAGR %	-76.55	18.38	244.49	-36.62	-63.52
Unlevered Free Cash Flow, 2 Yr. CAGR %	-70.99	18.47	185.71	-33.08	-45.41
Dividend Per Share, 2 Yr. CAGR %	9.54	26.49	15.47	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.7	12.09	13.74	14.94	10.96
Gross Profit, 3 Yr. CAGR %	10.92	14.02	16.65	18.71	8.35
EBITDA, 3 Yr. CAGR %	13.74	15.97	20.01	23	1.05
EBITA, 3 Yr. CAGR %	18.98	20.11	23.82	26.2	-0.12
EBIT, 3 Yr. CAGR %	22.22	22.14	25.66	26.69	-2.67
Earnings From Cont. Operations, 3 Yr. CAGR %	7.84	32.22	47.82	34.42	-1.96
Net Income, 3 Yr. CAGR %	7.84	32.22	47.82	33.87	-1.67
Normalized Net Income, 3 Yr. CAGR %	23.43	22.38	23.71	25.65	-1.5
Diluted EPS Before Extra, 3 Yr. CAGR %	7.8	32.14	47.71	33.73	-1.72
Accounts Receivable, 3 Yr. CAGR %	18.75	12.97	17.39	10.64	11.77
Inventory, 3 Yr. CAGR %	14.86	11.55	11.85	11.79	16.29
Net Property, Plant and Equip., 3 Yr. CAGR %	4.75	8.29	10.42	16.29	20.38
Total Assets, 3 Yr. CAGR %	9.11	11.49	13.44	18.96	21.64
Tangible Book Value, 3 Yr. CAGR %	20	16.68	21.68	12.26	9.77
Common Equity, 3 Yr. CAGR %	10.77	14.23	17.47	20.5	17.74
Cash From Operations, 3 Yr. CAGR %	-0.7	25.42	8.36	18.21	-1.22
Capital Expenditures, 3 Yr. CAGR %	28.22	32.7	18.97	23.34	27.24
Levered Free Cash Flow, 3 Yr. CAGR %	-59.13	12.91	-14.04	126.15	-62.01
Unlevered Free Cash Flow, 3 Yr. CAGR %	-52.96	12.92	-12.52	103.29	-49.39
Dividend Per Share, 3 Yr. CAGR %	14.47	16.96	16.96	10.06	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.92	11.63	12.66	13.27	12.11
Gross Profit, 5 Yr. CAGR %	7.76	12.8	14.42	15.16	11.45
EBITDA, 5 Yr. CAGR %	13.82	22.39	19.91	16.28	8.32
EBITA, 5 Yr. CAGR %	18.49	30.03	24.6	19.15	9.01
EBIT, 5 Yr. CAGR %	22.03	34.75	27.12	20.03	8.39
Earnings From Cont. Operations, 5 Yr. CAGR %	14.38	35.67	24.26	24.04	19.76
Net Income, 5 Yr. CAGR %	14.38	35.67	24.26	23.73	19.98
Normalized Net Income, 5 Yr. CAGR %	23.35	35.56	26.53	20.36	9.08
Diluted EPS Before Extra, 5 Yr. CAGR %	14.47	35.64	24.19	23.62	19.92
Accounts Receivable, 5 Yr. CAGR %	11.89	12.28	15.03	12.45	15.31
Inventory, 5 Yr. CAGR %	12.27	10.84	13.61	15.18	11
Net Property, Plant and Equip., 5 Yr. CAGR %	1.69	2.81	7.29	13.31	15.21
Total Assets, 5 Yr. CAGR %	5.9	7.36	11.44	16.25	16.89
Tangible Book Value, 5 Yr. CAGR %	16.08	20.27	21.09	12.75	14.3
Common Equity, 5 Yr. CAGR %	8.96	12.8	14.88	16.55	16.85
Cash From Operations, 5 Yr. CAGR %	5.49	26.7	9.62	9.24	9.71
Capital Expenditures, 5 Yr. CAGR %	3.61	4.04	18.72	41.52	19.08
Levered Free Cash Flow, 5 Yr. CAGR %	-46.93	42.85	-4.13	-8.66	-38.99
Unlevered Free Cash Flow, 5 Yr. CAGR %	-41.64	40.85	-3.21	-6.7	-27.56
Dividend Per Share, 5 Yr. CAGR %	8.45	14.87	14.87	9.86	9.86